Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

Avacta Group PLC

LON:AVCT

At Avacta we have developed Affimer technology, an engineered alternative to antibodies. Based on a small protein, Affimer technology can be quickly developed to bind with high specificity and affinity to a wide range of targets. Affimer proteins can be developed as therapeutic molecules and can be used in a wide range of other life sciences applications in research and diagnostics.

207 stories · page 9 of 11